A personalized mobile health coaching program reduced the incidence of gestational diabetes among high-risk pregnant women in an international randomized controlled trial, according to researchers reporting in The Lancet Digital Health.
The finding is notable because the study did not find a difference in average maternal body mass index 12 months after birth between women who received the digital intervention and those who received routine care alone. The result suggests that improved metabolic outcomes and gestational-diabetes prevention may be possible without a corresponding average change in weight.
A continuous program from pregnancy to postpartum
The study evaluated Bump2Baby and Me, known as B2B&Me, a smartphone-delivered coaching program that began in early pregnancy and continued for 12 months after birth. It was led by Sharleen O’Reilly of University College Dublin’s School of Agriculture and Food Science.
Researchers conducted the multicenter trial across Ireland, the United Kingdom, Spain and Australia. Participants were assigned to routine care alone or to routine care plus personalized mobile health coaching through the B2B&Me app.
According to the researchers, the trial is the first at this scale to provide a digital health intervention continuously through pregnancy and an extended postpartum period. That design is important because pregnancy-related health risks do not end at delivery, and a program that spans both periods can maintain contact during a major transition in care and daily routines.
Reduction without an average BMI difference
Gestational diabetes is strongly linked with overweight and obesity, and lifestyle interventions often focus on diet, physical activity and weight management. In the B2B&Me trial, however, the app group had a clinically important reduction in the number of women who developed gestational diabetes even though average maternal BMI at 12 months postpartum did not differ between the groups.
The distinction is more than a statistical detail. It challenges the assumption that weight change must be the primary visible marker of whether a preventive intervention is working. The researchers say the results show that gestational-diabetes prevention and metabolic-health improvements can be achieved independently of corresponding weight change.
O’Reilly said continuous, high-quality engagement with mobile health coaching can improve metabolic outcomes and reduce gestational-diabetes incidence independently of weight change. The intervention was designed to provide personalized support directly to women in real time through a smartphone.
What the trial tested
The source describes lifestyle interventions as typically addressing diet, physical activity and weight management. B2B&Me added personalized coaching to the care participants would ordinarily receive, rather than replacing routine maternity care.
That framing matters for potential clinical use. The result is not evidence that an app alone should substitute for clinical assessment or treatment. Instead, it indicates that a sustained digital layer of support, used alongside routine care, can affect an important pregnancy outcome in a high-risk population.
Digital programs may also offer a practical way to keep support available between appointments. The study’s approach was continuous rather than limited to a short prenatal program, extending support from early pregnancy through the first year postpartum. The researchers describe this duration as a defining feature of the trial.
Self-weighing was separately associated with lower BMI
Although the two study groups did not differ in average BMI at 12 months postpartum, the researchers reported another finding related to weight. Regular self-weighing with simple Bluetooth-enabled digital scales was independently associated with a significant reduction in BMI.
This does not change the main result: the reduction in gestational diabetes in the coaching group occurred without an average BMI difference between groups. But it points to a potentially useful component of digital support. Connected scales can make self-monitoring easier to integrate with a smartphone-based program, while allowing participants to track a measure that researchers found was independently associated with lower BMI.
Implications for care
The trial’s authors characterize the findings as having potential clinical implications. Gestational diabetes can affect pregnancy care and future metabolic health, so prevention in people at elevated risk is an important target. A program that reduces incidence while operating through routine care and a smartphone platform could offer a scalable support model, subject to further assessment of implementation and access.
The evidence supplied by this trial is strongest for the particular intervention and population studied: high-risk pregnant women receiving care across four countries. It does not establish that every health app, every coaching format or every population will produce the same result. Nor does the reported finding identify every mechanism behind the improvement.
Still, the study adds a useful practical message to digital health research. A preventive program can be evaluated by health outcomes, not only by whether it produces a change in body weight. For high-risk pregnancies, continuous personalized coaching may provide a new route to reducing gestational diabetes while supporting women through pregnancy and the year after birth.
This article is based on reporting by Medical Xpress. Read the original article.
Originally published on medicalxpress.com
